Silver Book Fact

An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay tumor growth. Patients lived a median of 3.7 months before their tumors got worse–as opposed to 1.9 months.

Szabo L. New Weapons Do Battle with Kidney Cancer. USA Today. June 4 2006. http://www.usatoday.com/news/health/2006-06-04-kidney-cancer_x.htm?csp=34

Reference

Title
New Weapons Do Battle with Kidney Cancer
Publication
USA Today
Publication Date
June 4 2006
Authors
Szabo L
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Intensity modulated radiation therapy (IMRT) precisely maps and targets tumors with better tumor control and fewer side effects than other forms of radiation. In one study, IMRT increased the success…  
  • Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.  
  • A drug that can reduce the risk of breast cancer in high-risk women costs approximately $1,050 per year. The average cost per year for surgery or other invasive methods of…  
  • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.